This on-demand activity features presentations that examine the consequences of untreated TD on the quality of life in patients taking antipsychotic medications, and discuss best practices for overcoming barriers that interfere with patient adherence to VMAT2 inhibitors.
After participating in this activity, participants should be better able to:
To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation by May 1, 2021. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.
This on demand, knowledge-based activity (Universal Activity Number JA0006201-0000-20-161-H01-P) has been approved for a maximum of 1.5 contact hours (0.15 CEUs).
As a Jointly Accredited Organization, North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content. Variable credit for partial attendance may not be awarded. Full attendance is required for all CE activities.
Instructional Level: Advanced
This activity will award 1.5 continuing education credits.
North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.